Journal
PLoS Neglected Tropical Diseases
Publication Date
5-1-2023
Volume
17
Issue
5
First Page
e0011365
Document Type
Open Access Publication
DOI
10.1371/journal.pntd.0011365
Rights and Permissions
Opoku NO, Doe F, Dubben B, Fetcho N, Fischer K, et al. (2023) A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis. PLOS Neglected Tropical Diseases 17(5): e0011365. https://doi.org/10.1371/journal.pntd.0011365. Copyright: © 2023 Opoku et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Citation
Opoku, Nicholas O.; Fetcho, Nicole; Fischer, Kerstin; Fischer, Peter U.; Goss, Charles W.; Hong, Augustine R.; Lew, Daphne; Weil, Gary J.; and et al., "A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis." PLoS Neglected Tropical Diseases. 17, 5. e0011365 (2023).
https://digitalcommons.wustl.edu/oa_4/1839
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
